Esperion Therapeutics, Inc. Profile Avatar - Palmy Investing

Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoi…

Drug Manufacturers - Specialty & Generic
US, Ann Arbor [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of ESPR's Analysis
CIK: 1434868 CUSIP: 29664W105 ISIN: US29664W1053 LEI: - UEI: -
Secondary Listings
ESPR has no secondary listings inside our databases.